Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06435858
What this trial is testing

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Cantonal Hospital Graubuenden 16
Early research (Phase 1)Study completedNCT07367555
What this trial is testing

Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients

Who this might be right for
Diabete Mellitus
Ariba Shafiq 360
Large-scale testing (Phase 3)Study completedNCT03215069
What this trial is testing

Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes

Who this might be right for
Gestational Diabetes
Mount Sinai Hospital, Canada 91
Testing effectiveness (Phase 2)WithdrawnNCT05885074
What this trial is testing

Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors

Who this might be right for
ObesityWeight Loss
University of Alabama at Birmingham
Large-scale testing (Phase 3)Not Yet RecruitingNCT07488689
What this trial is testing

Assessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory Dysfunction

Who this might be right for
Septic Shock
University Hospital, Strasbourg, France 568
Large-scale testing (Phase 3)Ended earlyNCT03419624
What this trial is testing

The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients

Who this might be right for
ObesityDiabetes Mellitus, Type 2
Universitätsklinikum Hamburg-Eppendorf 13
Not applicableStudy completedNCT05915884
What this trial is testing

The Triglyceride/Glucose Index and SGLT-2 Inhibitors

Who this might be right for
Metabolic DiseaseDiabetes
Samsun Education and Research Hospital 55
Post-approval studies (Phase 4)Study completedNCT02920918
What this trial is testing

Treatment of Diabetes in Patients With Systolic Heart Failure

Who this might be right for
Heart Failure, SystolicDiabetes Mellitus, Type 2
Virginia Commonwealth University 36
Not applicableStudy completedNCT03918148
What this trial is testing

Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)

Who this might be right for
Type 2 Diabetes Mellitus
University of Campania Luigi Vanvitelli 1,150
Not applicableStudy completedNCT06797115
What this trial is testing

Hydroxyl Free Radical Associated Effects of SGLT-2 Inhibitors in Type 2 Diabetes

Who this might be right for
T2DM
University of Pecs 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06778967
What this trial is testing

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 1,100
Not applicableActive Not RecruitingNCT07063316
What this trial is testing

SGLT2 Inhibitors and Renal Anemia in Japan: RWD

Who this might be right for
Chronic Kidney Disease
Boehringer Ingelheim 15,000
Post-approval studies (Phase 4)Active Not RecruitingNCT05590143
What this trial is testing

ProMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2

Who this might be right for
Acute Kidney InjuryCardiac SurgerySodium-Glucose Transporter 2 Inhibitor
Amsterdam UMC 784
Testing effectiveness (Phase 2)UnknownNCT05314725
What this trial is testing

Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial

Who this might be right for
Postoperative HyperglycemiaStress Hyperglycemia
Zealand University Hospital 24
Large-scale testing (Phase 3)UnknownNCT05373004
What this trial is testing

Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease

Who this might be right for
Diabetic Nephropathy Type 2
Omar Tarek Elfarargi 212
Large-scale testing (Phase 3)Looking for participantsNCT06982079
What this trial is testing

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Stage 5CKD Stage 4
Ain Shams University 60
Testing effectiveness (Phase 2)WithdrawnNCT04640493
What this trial is testing

SGLT2-Inhibitors for Sleep Apnea in Heart Failure

Who this might be right for
Heart FailureSleep Disordered Breathing
Columbia University
Post-approval studies (Phase 4)Ended earlyNCT02462421
What this trial is testing

Pharmacogenetics of SGLT2 Inhibitors

Who this might be right for
Diabetes MellitusGoutHyperuricemia
University of Maryland, Baltimore 30
Large-scale testing (Phase 3)Study completedNCT03723252
What this trial is testing

Dapagliflozin Efficacy and Action in NASH

Who this might be right for
Nonalcoholic Steatohepatitis
Nanfang Hospital, Southern Medical University 154
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682350
What this trial is testing

SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial

Who this might be right for
Kidney Transplant RecipientSodium Glucose Co-Transporter 2 InhibitorsNon-Diabetic Patients+3 more
Odense University Hospital 184
Next Page